10-K: Chemours Reports 2025 Net Loss, Navigates PFAS Litigation

The Chemours Company reported a significant net loss in 2025, driven by substantial litigation charges and operational challenges in its Titanium Technologies and Advanced Performance Materials segments, despite growth in Thermal & Specialized Solutions.

Summary

• Net sales increased slightly by $26 million (0%) to $5.8 billion for the year ended December 31, 2025, compared to $5.8 billion in 2024.
• The company shifted from a net income of $69 million in 2024 to a net loss of $386 million in 2025.
• Basic loss per share was $2.57 in 2025, compared to earnings of $0.46 in 2024.
• Cost of goods sold increased by $266 million (6%) to $4.9 billion, primarily due to higher raw material costs.
• Selling, general, and administrative (SG&A) expense rose by $201 million (34%) to $799 million, largely attributable to $270 million in litigation-related charges for the New Jersey settlement.
• The Thermal & Specialized Solutions segment's net sales increased by $236 million (13%) to $2.1 billion, driven by a 5% price increase and 8% volume growth, particularly for Opteon™ Refrigerant blends.
• The Titanium Technologies segment's net sales decreased by $143 million (6%) to $2.4 billion, due to a 6% price decrease and 1% volume decrease, exacerbated by $41 million in operational disruption costs.
• The Advanced Performance Materials segment's net sales decreased by $63 million (5%) to $1.3 billion, primarily from an 8% volume decrease due to an operational outage at the Washington Works site and the exit of the SPS Capstone™ product line.
• Operating cash flows significantly improved to $264 million in 2025 from a $633 million use in 2024, aided by the release of $592 million in restricted cash from the U.S. public water settlement.
• Environmental remediation liabilities increased to $618 million in 2025 from $571 million in 2024, with $320 million related to Fayetteville Works.
• Accrued litigation liabilities increased to $484 million in 2025 from $208 million in 2024, including $270 million for the New Jersey settlement agreement.
• In January 2026, the company entered into agreements to sell ten parcels of land in Kuan Yin, Taiwan, for approximately $360 million, with proceeds intended to reduce debt obligations.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a challenging period marked by a significant net loss driven by substantial litigation costs and operational setbacks in key segments, despite some positive growth in Thermal & Specialized Solutions. The ongoing environmental and regulatory uncertainties, coupled with high indebtedness, present considerable headwinds.

Positives

• The Thermal & Specialized Solutions segment demonstrated strong performance, with net sales increasing by 13% to $2.1 billion and Adjusted EBITDA growing by 17% to $670 million, driven by increased demand for Opteon™ Refrigerants.
• Operating cash flows significantly improved, moving from a $633 million use in 2024 to a $264 million generation in 2025, partly due to the release of $592 million in restricted cash from the U.S. public water settlement.
• The company successfully entered into agreements in January 2026 to sell land in Kuan Yin, Taiwan, for approximately $360 million, with the intent to use proceeds for debt reduction.
• Cost savings of $50 million in 2023 and $140 million in 2024 were achieved under the Titanium Technologies Transformation Plan.
• The expansion of Opteon YF capacity at the Corpus Christi, Texas facility by approximately 40% was mechanically completed in the fourth quarter of 2024.
• Chemours' near-term science-based emissions reduction targets were approved by the Science Based Targets initiative (SBTi) in May 2024, aligning with climate commitments.
• An improvement project at the Louisville, Kentucky manufacturing site successfully reduced HFC-23 emissions, becoming operational in October 2022.

Negatives

• The company reported a net loss of $386 million in 2025, a significant decline from the net income of $69 million in 2024.
• Basic loss per share was $2.57 in 2025, compared to basic earnings per share of $0.46 in 2024.
• Selling, general, and administrative (SG&A) expense increased substantially by $201 million (34%) to $799 million, primarily due to $270 million in litigation-related charges for the New Jersey settlement.
• The Titanium Technologies segment experienced a 6% decrease in net sales and a 52% decrease in Adjusted EBITDA, impacted by lower demand, reduced production levels, and $41 million in operational disruption costs.
• The Advanced Performance Materials segment saw a 5% decrease in net sales and a 33% decrease in Adjusted EBITDA, largely due to an operational outage at the Washington Works site and the exit of the SPS Capstone™ product line.
• Interest expense, net increased by $6 million (2%) to $269 million, driven by higher interest rates on variable rate debt and increased debt principal.
• A goodwill impairment charge of $56 million was recognized in the Advanced Performance Materials segment in 2024.
• Environmental remediation liabilities increased to $618 million, with a potential for additional liabilities up to approximately $620 million above the accrued amount.
• Accrued litigation liabilities increased to $484 million, primarily due to the New Jersey settlement.
• An unplanned outage at the Washington Works site in January 2026 is expected to result in a negative earnings impact of $20 million to $25 million for the Advanced Performance Materials segment in the first quarter of 2026.
• The company made a strategic decision to temporarily idle one of its mineral sands mines in northern Florida in January 2026.

Risks

• Results of operations could be adversely affected by significant litigation and other commitments and contingencies, particularly PFAS-related claims and indemnification obligations to former parent companies (EID, Corteva, DuPont).
• Extensive environmental and health and safety laws and regulations may result in unanticipated loss or liability, or significant additional compliance costs, reducing profitability or liquidity.
• Exposure to civil or criminal litigation from investors and/or regulatory entities, and significant financial and operational costs, may arise from the 2024 audit committee internal review.
• Operating as a multi-national corporation presents risks from global and regional economic, political, and capital market conditions, including inflation, interest rates, currency exchange rates, and geopolitical tensions.
• Inability to innovate and successfully introduce new products, or new technologies reducing demand for existing products, could adversely affect profitability.
• Price fluctuations in energy and raw materials, and the inability to renew raw materials contracts on favorable terms, could significantly impact operating results.
• Reported results and financial condition could be adversely affected by currency exchange rates and currency devaluation, impairing competitiveness.
• Potential for significant non-cash charges if long-lived assets, including goodwill, become impaired.
• Changes in tax rates, adoption of tax legislation, or exposure to additional tax liabilities may adversely affect results.
• Dependence on cash flows from operating subsidiaries to fund debt obligations, MOU escrow funding requirements, and capital expenditures.
• Failure to meet key financial and non-financial targets could negatively impact business value and stock price.
• Pandemics, epidemics, or other infectious disease outbreaks may have a material adverse effect on business operations.
• Hazards associated with chemical manufacturing, storage, containment, and transportation could lead to operational interruptions, personal injury, environmental damage, and fines.
• Business disruptions from environmental, weather, and natural disasters, as well as other events outside of control, could seriously impact operations.
• Adverse impacts from actions of joint ventures, their participants, or other partners.
• Business disruptions and security breaches, including cybersecurity incidents and risks from new and evolving technologies like artificial intelligence (AI).
• Material impact from a failure of information technology infrastructure, especially with an unsupported enterprise resource planning (ERP) software platform.
• Failure to maintain effective internal control over financial reporting or identify material weaknesses could lead to inaccurate financial results or fraud.
• Success depends on the ability to attract and retain key employees and develop talented personnel for succession.
• Current level of indebtedness could adversely affect financial condition or liquidity, and difficulty fulfilling obligations.
• Need for additional capital in the future, which may not be obtainable on favorable terms, or at all.
• Restrictive covenants in debt agreements limiting current and future operations.
• Variable rate indebtedness subjects the company to interest rate risk, potentially increasing service obligations.
• Adverse developments affecting financial markets and currency exchange rates, including events involving liquidity, defaults, or non-performance by financial institutions, could adversely affect business.

Future Outlook

The company anticipates working capital outflows in the first half of 2026 due to seasonal timing and the settlement of higher accounts payable from Q4 2025 plant maintenance. Capital expenditures for 2026 are expected to be between $250 million and $300 million. Management believes current liquidity sources are sufficient to fund planned operations and meet obligations through at least the end of February 2027. The company expects to reclassify approximately $7 million of net pre-tax loss from foreign currency forward contracts and $3 million of net pre-tax loss from interest rate swaps to earnings over the next 12 months. Long-term global TiO2 pigment demand is expected to correlate with global GDP growth rates, and the company will continue to invest in R&D for next-generation refrigerants to drive sustainable growth with low global warming potential (GWP) solutions. The Advanced Performance Materials segment is expected to benefit long term from secular growth in clean energy and advanced electronics. The European Commission is expected to publish a report on the effects of the HFC phase-down regulation by January 1, 2030. The ECHA Risk Assessment Committee and Socio-economic Analysis Committees are expected to complete their scientific evaluation of the PFAS restriction proposal by the end of 2026, with estimated earliest entry into force of restrictions in 2027. The U.S. EPA intends to retain MCLs for PFOS and PFOA, with rulemaking for additional time for compliance, and to rescind other MCLs and the hazard index.

Management Comments

• Our refreshed corporate strategy, Pathway to Thrive, capitalizes on the fundamental strengths of our businesses, our incredible talent, and the competitive differentiators that make us the best owners and operators of Chemours.
• We are committed to creating value for our customers and stakeholders by leveraging strengths that we use to create competitive advantage: our innovation and technical expertise, our ability to operate complex manufacturing sites safely, our deep customer relationships based on trust and reliability, and our talented workforce.
• Management believes that its relations with employees and labor organizations are good.
• Management believes that its relations with contract workers are good.
• Management believes the Company's accounting treatment and disclosure for the matters discussed are appropriate based on the facts and circumstances for each matter.
• Management does not believe that any loss, in excess of amounts accrued, related to remediation activities at any individual site will have a material impact on our financial position or cash flows for any given year, as such obligation can be satisfied or settled over many years.

Industry Context

StockSavvy.ai notes that Chemours operates in a diverse chemical landscape, balancing mature markets like titanium dioxide (TiO2) with high-growth specialty areas such as low GWP refrigerants and advanced materials for semiconductors and clean energy. The company's 'Pathway to Thrive' strategy, focusing on operational excellence, enabling growth in rapidly expanding end-markets (e.g., data center cooling), and portfolio optimization, aligns with broader industry trends towards sustainability, technological advancement, and higher-margin product offerings. The significant regulatory pressures surrounding PFAS and HFCs continue to shape product development and market demand, driving innovation in environmentally compliant solutions. However, intense competition from global and regional players, particularly in TiO2 and fluorochemicals, remains a persistent challenge, impacting pricing and market share.

Management Changes

Corporate Governance

Legal Proceedings

• Ongoing PFAS-related litigation, including approximately 12,200 matters in the Aqueous Film Forming Foam (AFFF) Multi-District Litigation (MDL).
• U.S. public water system class action settlement for PFAS drinking water claims, with $1,185 million contributed to a qualified settlement fund (Chemours' share 50%), which received final court approval in February 2024.
• New Jersey settlement agreement with the State of New Jersey to resolve statewide PFAS claims and legacy contamination at four current and former operating sites, totaling $875 million over 25 years (Chemours' portion $270 million on a net present value basis).
• Settlement agreement with the State of Ohio for PFAS claims, with Chemours contributing $55 million.
• Supplemental payment of $13 million to the State of Delaware for PFAS-related natural resource damages.
• Hoosick Falls class action lawsuit resolved for a total of $27 million (Chemours' portion $13.5 million), with preliminary court approval in November 2025.
• Approximately 844 asbestos-related lawsuits pending against EID, with Chemours assuming current and future SGPI asbestos and product liability claims as of March 2025.
• 24 pending lawsuits against EID alleging benzene-related illnesses.
• Governmental and regulatory inquiries regarding PFAS, including a grand jury subpoena from the U.S. Department of Justice.
• Ongoing litigation and environmental remediation matters at Fayetteville Works, North Carolina, under a Consent Order and Addendum, requiring PFAS loading reductions and provision of permanent drinking water supplies.
• Civil summons filed before the Court of Rotterdam by four Dutch municipalities seeking liability declarations related to Dordrecht Works' PFOA emissions, with a court ruling in September 2023 finding defendants liable for certain emissions.
• A conditional fine of €1 million from the Dutch ILT agency for HFC-23 quota exceedance at Dordrecht Works, paid in June 2025, with an objection submitted.
• The European Commission imposed a 200% quota reduction penalty applicable in 2026 on Dordrecht Works for infringement of the F-gas regulation, with an application for annulment filed.
• West Virginia Rivers Coalition filed a Clean Water Act complaint against the Chemours Washington Works facility, alleging effluent discharge limit exceedances, resulting in a preliminary injunction in August 2025.
• Securities-related class actions and stockholder derivative actions filed in Delaware federal and state courts following the 2024 audit committee internal review, alleging violations of securities laws and breach of fiduciary duty.

Related Party Transactions

• Separation-related agreements with EID (now a subsidiary of Corteva), DuPont, and Corteva, including an employee matters agreement, tax matters agreement, transition services agreement, and intellectual property cross-license agreement, governing the post-separation relationship and allocation of assets/liabilities.
• Memorandum of Understanding (MOU) and PFAS Insurance Proceeds Memorandum of Understanding (PFAS Insurance MOU) with DuPont, Corteva, and EID for cost-sharing of potential future legacy PFAS liabilities and allocation of insurance proceeds.
• Indemnification obligations to EID for certain liabilities, including defense costs and damages awards related to litigation matters.
• Transactions with equity method investees, including Chemours-Mitsui Fluorochemicals Company, Ltd., The Chemours Chenguang Fluoromaterials Company Limited, and Changshu 3F Zhonghao New Chemical Materials Co., Ltd., involving net sales and purchases.

Stakeholder Impact

• Shareholders are impacted by the net loss, stock price volatility, and potential dilution from future equity issuances, but may benefit from strategic growth initiatives and debt reduction efforts.
• Employees are affected by restructuring programs, such as the Titanium Technologies Transformation Plan and the SPS Capstone™ Exit, which involve employee separation charges, while also benefiting from competitive compensation, professional development, and a strong safety culture.
• Customers benefit from the company's innovation in low GWP refrigerants (Opteon™) and high-end polymers, but may experience supply disruptions due to operational outages like the one at Washington Works.
• Communities, particularly those near manufacturing sites, are directly impacted by environmental remediation efforts related to PFAS contamination, with settlements aiming to address concerns and provide clean drinking water.
• Suppliers are affected by changes in raw material demand and pricing, as well as the company's working capital management actions, including agreements on longer standard accounts payable payment terms.
• Creditors are influenced by the company's level of indebtedness, its ability to service debt obligations, and the restrictive covenants in debt agreements, with asset sales intended to improve the leverage profile.

Next Steps

• Complete the sale of land in Kuan Yin, Taiwan, by mid-year 2026, subject to closing conditions and regulatory approval.
• Address the negative earnings impact of $20 million to $25 million for the Advanced Performance Materials segment in Q1 2026 due to the Washington Works operational disruption.
• Continue to implement abatement technology to reduce discharges at Dordrecht Works below conditional fine levels.
• Engage with regulatory authorities on the revised permit application for Dordrecht Works.
• Complete further briefing by March 2026 on EPA's partial vacatur of the PFAS NPDWR regulation.
• Oral argument scheduled for March 2026 for the appeal of the Washington Works preliminary injunction.
• Trial scheduled for August 2026 for three individual well owner cases in Fayetteville.
• Trial scheduled for March 2027 for the Mohawk lawsuit in Georgia state court.
• Continue to evaluate the impact of the U.S. Tax Act for future tax years, especially regarding interest expense deductibility and U.S. taxation of non-U.S. earnings.
• Continue to monitor macroeconomic and industry-specific conditions for indicators of potential impairment of goodwill and long-lived assets.
• Work with NJ DEP and potentially LSRPs to determine appropriate RFS amounts and review future scope of remediation for the four New Jersey sites.
• Contribute $4 million to pension plans in 2026.
• Refinance $495 million 5.375% senior unsecured notes due May 2027.

Key Dates

Recommendation

The company reported a substantial net loss in 2025, a significant deterioration from the prior year's net income, primarily due to massive litigation charges and operational underperformance in two out of three key segments. While the Thermal & Specialized Solutions segment shows strength, the ongoing and escalating PFAS-related liabilities, coupled with operational disruptions and a high debt load, present considerable financial and reputational risks. The uncertainty surrounding future environmental costs and legal outcomes, along with the need to refinance significant debt maturities, suggests a challenging outlook for investors.

Keywords

Chemicals, Performance Chemicals, Fluoropolymers, Titanium Dioxide, TiO2, Refrigerants, Opteon, PFAS, Environmental Liabilities, Litigation, SEC Filing, 10-K, Financial Results, Manufacturing, Specialty Chemicals, Corporate Governance, Risk Management, Sustainability, Thermal Management, Advanced Materials, Capital Expenditures, Debt, Share Repurchase, Supply Chain, Cybersecurity, AI, Regulatory Compliance